Post-onset treatment of AIA using endogenous MCP-1 inhibitors improved clinical signs of arthritis and histological scores measuring joint destruction, synovial lining, macrophage infiltration, and bone erosion (66). The gene discussed is CCL2; the disease is Arthritis.